Roche Acquires PathAI for $750 Million to Advance AI in Pathology
Roche has reached an agreement to purchase PathAI for $750 million, aiming to enhance the application of artificial intelligence in disease diagnosis by pathologists.
Latest AI stories from Tech.
Roche has reached an agreement to purchase PathAI for $750 million, aiming to enhance the application of artificial intelligence in disease diagnosis by pathologists.
As tech companies invest heavily in massive new data centers, the implications for energy consumption and power grids are becoming increasingly contentious.
In a recent commentary, Jim Cramer identified Alphabet and other significant companies that are influencing the AI interface and cloud services landscape.
As the financial sector explores AI integration, the importance of hiring digitally savvy individuals with strong critical thinking skills is becoming increasingly evident.
The company behind the Claude AI tool is reportedly receiving investment offers that may push its valuation close to $1 trillion, potentially exceeding OpenAI's worth.
Silicon Valley's leading companies are shifting from being primarily cash-generating entities to significant players in infrastructure investment, with $725 billion in AI spending impacting their free cash flow.
Eric Trump and Donald Trump Jr. have invested in a fund that aims to direct capital into companies within the artificial intelligence and drone sectors, areas supported by their father, President Trump.
Recent announcements regarding AI developments raise significant concerns about the future of employment, as highlighted by MarketWatch.
An IBD 50 stock is attracting investor attention due to its unique capabilities, particularly in AI data centers and U.S. Navy contracts, suggesting potential for significant growth.
The FDA is revisiting a rare cancer treatment it had turned down earlier this year, amidst discussions on drug pricing and advancements in biotech.
OpenAI has released a health policy blueprint while Dexcom updates its continuous glucose monitoring technology, alongside concerns regarding whole body scans.
As generative AI becomes integral to student life in Canada, concerns arise regarding its impact on personal identity, even as institutions emphasize misconduct and detection.
David Sacks has stepped down from his influential position in the White House, marking a notable change in the administration's technology policy.
Research indicates that brief interactions with AI prior to lectures may improve brain synchrony and learning outcomes among students, particularly noted during the pandemic.
Brittany Trang highlights a potential shift in the dialogue surrounding AI in health care, suggesting that discussions may be moving beyond initial hype.
As artificial intelligence becomes increasingly integrated into healthcare claims processes, this discussion highlights the importance of consumer protections at both federal and state levels.
As fundraising discussions continue, DeepSeek's valuation is reportedly nearing $45 billion, with significant interest from China’s ‘Big Fund’ and Tencent.
Samsung's impressive rise in stock market value to $1 trillion has contributed to a new record for South Korea's Kospi index, reflecting growing enthusiasm for AI technologies.
The introduction of Synthegy, an AI system, is transforming how chemists approach molecule design, enabling them to use natural language for complex tasks.
As artificial intelligence becomes increasingly prevalent in American schools, educators are adapting to its integration, supported by significant investments from tech giants.